You are here

  • Home
  • Archive
  • Volume 11, Issue 8
  • A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma

 

Online download statistics by month:

Online download statistics by month: August 2023 to July 2025

AbstractFullPdf
Aug 202311021112253
Sep 202334934983
Oct 202321421463
Nov 202325025078
Dec 202316216376
Jan 202415615699
Feb 2024959643
Mar 202413013187
Apr 202411911962
May 202411812265
Jun 202411011070
Jul 2024879057
Aug 2024767532
Sep 20245555650
Oct 202412512570
Nov 202413013268
Dec 202411111246
Jan 2025656532
Feb 2025696932
Mar 2025747452
Apr 2025868669
May 2025555550
Jun 2025515251
Jul 2025110
Total379038132188